Colon to Rectum

Lancet Gastroenterol Hepatol. 2022;7(8):747–54

van Toledo DEFWM, IJspeert JEG, Bossuyt PMM, Bleijenberg AGC, van Leerdam ME, van der Vlugt M, Lansdorp-Vogelaar I, Spaander MCW, Dekker E

Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: A population-based study


Background: Adenoma detection rate (ADR) is a well-established quality indicator for colonoscopy and is inversely associated with the incidence of interval post-colonoscopy colorectal cancer (CRC). However, interval post-colonoscopy CRCs frequently develop from serrated polyps, which are not included in the ADR. Therefore, the proximal serrated polyp detection rate (PSPDR) has been proposed as a quality indicator, but its association with interval post-colonoscopy CRC has not been studied. The aim of the present study was to evaluate this potential association based on data collected in the Dutch CRC screening program.
Methods: In this population-based study, using colonoscopy data from the Dutch fecal immunochemical test-based CRC screening program and cancer data from the Netherlands Cancer Registry, the authors evaluated the association between endoscopists’ individual PSPDR and their patients’ risk of interval post-colonoscopy CRC with a shared frailty Cox proportional-hazard regression analysis. Participants in the screening program who were eligible for inclusion were aged 55–76 years, had a positive fecal immunochemical test (cut-off 15 μg Hb/g feces at start and changed mid-2014 to 47 μg Hb/g feces), were asymptomatic, and underwent a colonoscopy between January 1, 2014, and December 31, 2020. The PSPDR was defined as the proportion of colonoscopies in which at least 1 serrated polyp proximal to the descending colon was detected, confirmed by histopathology. The ADR was defined as the proportion of all colonoscopies in which at least 1 conventional adenoma was detected, confirmed by histopathology. Detection rates were determined for each endoscopist individually. The authors additionally evaluated the risk of interval post-colonoscopy CRC for endoscopists with a PSPDR and ADR above the median versus endoscopists with either 1 or both parameters below the median.
Findings: During the study period, 329,104 colonoscopies were done, of which 277,555, done by 441 endoscopists, were included in the PSPDR calculations. The median PSPDR was 11.9% (interquartile range [IQR], 8.3–15.8%) and median ADR was 66.3% (IQR, 61.4–69.9%). The correlation between the PSPDR and ADR was moderate (r = 0.59; p < 0.0001). During a median follow-up of 33 months (IQR, 21–42 months), 305 interval post-colonoscopy CRCs were detected. For each percentage point increase in PSPDR, the adjusted interval post-colonoscopy CRC hazard was 7% lower (hazard ratio [HR] = 0.93, 95% confidence interval [CI]: 0.90–0.95; p < 0.0001). Compared with endoscopists with a PSPDR > 11.9% and ADR > 66.3%, the HR of interval post-colonoscopy CRC for endoscopists with a low PSPDR and high ADR was 1.79 (95% CI: 1.22–2.63), for endoscopists with a high PSPDR and low ADR was 1.97 (95% CI: 1.19–3.24), and for endoscopists with a low PSPDR and low ADR was 2.55 (95% CI: 1.89–3.45).

Interpretation: The proximal serrated polyp detection rate (PSPDR) of an endoscopist is inversely associated with the incidence of interval post-colonoscopy colorectal cancer (CRC). Implementation of PSPDR monitoring, in addition to adenoma detection rate monitoring, could optimize CRC prevention.

Prof. Dr. E. Dekker, Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands,
E-Mail: e.dekker@amsterdamumc.nl

DOI: 10.1016/s2468-1253(22)00090-5

Back to overview

this could be of interest:

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from 3 phase 3, multicenter, double-blind, randomized trials

Lancet. 2022;399(10341):2113–28

Budesonide maintenance in microscopic colitis: Clinical outcomes and safety profile from a population-based study

Am J Gastroenterol. 2022;117(8):1311–5

More articles on the topic